IMV Inc.

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific & Clinical Advisors
    • Partnerships
  • The DPX Platform
    • Overview
    • Scientific Publications & Posters
  • Clinical Pipeline
    • Overview
    • DPX-Survivac
    • DPX-RSV
    • DPX-COVID-19
    • Clinical Trials
  • News & Events
    • Press Releases
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contact Us
    • FAQ
  • Careers
    • Overview
    • Life at IMV
  • Contact

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events, Webcasts & Presentations
    • Overview
    • Presentations
    • Scientific Publications & Posters
    • Email Alerts
  • Financial Info
    • Financial Results
    • Tax Info
    • Proxy Info
    • Stock Option Plan
    • Deferred Share Unit Plan
  • Stock Data
    • NASDAQ: IMV
    • TSX: IMV
    • Analyst Coverage
  • Filings
    • SEC Filings
    • SEDAR
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact Us
  • FAQ
May 07, 2020 10:16am EDT

IMV Inc. Announces Closing of $25.1 Million Private Placement

May 04, 2020 7:05am EDT

IMV Inc. to Announce First Quarter 2020 Results and Host a Conference Call and Webcast on May 15, 2020

Apr 30, 2020 7:05am EDT

IMV Announces Proposed $22.3 Million Private Placement

Apr 21, 2020 5:05pm EDT

IMV to Participate in Adelaide Capital’s Virtual COVID & Healthcare Mini Conference

Mar 30, 2020 5:05pm EDT

IMV Inc. Announces Fourth Quarter and Full Year 2019 Financial and Operational Results

Mar 30, 2020 7:05am EDT

IMV Inc. Provides Updates on the Development of DPX-COVID-19 Vaccine, Its Ongoing Business and Clinical Operations

Mar 25, 2020 7:05am EDT

IMV to Announce Fourth Quarter and Full Year 2019 Financial and Operational Results and Host Investor Conference Call and Webcast on March 31, 2020

IMV Inc. Establishes At-the-Market Facility
Mar 18, 2020 8:23am EDT

IMV Inc. Establishes At-the-Market Facility

IMV Inc. Launches Plans to Advance Clinical Development of a Vaccine Candidate Against COVID-19
Mar 18, 2020 7:05am EDT

IMV Inc. Launches Plans to Advance Clinical Development of a Vaccine Candidate Against COVID-19

Feb 25, 2020 3:05am EST

IMV Inc. Announces Breakthrough Data from DeCidE1, its Ongoing Phase 2 Study of DPX-Survivac in Patients with Advanced Recurrent Ovarian Cancer

RSS
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...35
  • Next
  • Email Alerts
  • Contacts
  • RSS News Feed
IMV Inc.
About Us The DPX Platform Clinical Pipeline News & Events Investors Careers Contact
Twitter LinkedIn Youtube
© 2021 IMV Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap